PILA PHARMA

We are a biotech company pioneering development of a novel oral drug for treatment of #obesity & #diabetes based on #TRPV1 inhibition 💊
Follow for news!

[PILA PHARMA @PilaPharma]

We're very honoured to share that the @AmDiabetesAssn (ADA), @ADA_DiabetesPro is featuring PILA PHARMA AB in the "Thought Leadership Film Series", a part of ADA’s 81st Scientific Sessions program in June 2021, starting today. #Diabetes #research #T2D
https://t.co/HlKJOTgkdb

[PILA PHARMA @PilaPharma]

Press: https://t.co/cj1L8uiTvg

[PILA PHARMA @PilaPharma]

📖 AGM 2026 - the shareholders annual gathering 🌟

Earlier this week, @PILAPHARMA held its annual general meeting at its offices in Malmö, an annual opportunity for shareholders to meet and discuss with management and board around the status and future of the company! 💡

[PILA PHARMA @PilaPharma]

It was a meeting a good turnout of shareholders, coming with some interesting questions, discussions and great mingle time afterwards! 💬 We hope more shareholders will participate in future meetings and events

The list of topics and decisions can be found in the press release

[PILA PHARMA @PilaPharma]

🚨 Reminder! Registration for the annual general meeting on 19 May: Today 08 May, is the last for shareholders registration if shares are held privately!

All documents and more information can be found on the dedicated AGM webpage.
https://t.co/LvIjwHvMLV

[PILA PHARMA @PilaPharma]

https://t.co/LvIjwHvMLV

[PILA PHARMA @PilaPharma]

🚨 Reminder! Registration for the annual general meeting on 19 May: Today 08 May, is the last for shareholders registration if shares are held privately!

If you have shares registered by a custodian, registration is due by Tuesday 12 May! 🏦

[PILA PHARMA @PilaPharma]

If you are a shareholder but unable to attend, we highly recommend to sign a power of attorney (Fullmakt) and sent to Chairman of the Board, Dorte X. Gram, equally on [email protected].

All documents and more information can be found on the dedicated AGM webpage.

[PILA PHARMA @PilaPharma]

For those who missed the latest interview, it was conducted with @BioStock_SWE. Here our CEO Gustav H. Gram commented on the exposure results from the preclinical study, as well as the path forward to clinical trials in obesity.
Link: https://t.co/8VEi7cgx7L

[PILA PHARMA @PilaPharma]

🎤 UPCOMING INVESTOR EVENTS AND INTERVIEWS - PRESENTING AT @REDEYE_ #DIABETES DAY ON 06 MAY

@PILAPHARMA will have corporate interviews and presentations at several locations today, May 06, 2026. Please find the links below!

[PILA PHARMA @PilaPharma]

📚 06 May: #CVX Venture Partner Meeting (in-person, invite only)
Copenhagen, Denmark – 17:00 CEST
Link: https://t.co/w9JyvfHF5j

[PILA PHARMA @PilaPharma]

Link to presentation: https://t.co/fzYP7EJ3f5

[PILA PHARMA @PilaPharma]

🚂 "We keep going, the operational train is moving and we're on the right path"

We recently participated in an #investment night hosted by #AktieInfo / John Stihøj in #Århus, Denmark 🇩🇰

[PILA PHARMA @PilaPharma]

You can also find their latest equity analysis on PILA PHARMA here 🌟
Link to Stock Analysis (in Danish) https://t.co/MT2HWpDhwm

[PILA PHARMA @PilaPharma]

Stock Analysis: https://t.co/MT2HWpDhwm

[PILA PHARMA @PilaPharma]

💰 Come join us for an #investment night and introduction to @PILAPHARMA and our innovate pill solution for #obesity and #diabetes! 💊

Tomorrow our CEO Gustav H. Gram will be with #AktieInfo / John Stihøj at their event in #Århus, Denmark 🇩🇰

[PILA PHARMA @PilaPharma]

Event: https://t.co/ldpmYaMzOf